# Prolonged oral etoposide as second-line therapy for platinum-resistant and platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study.

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/prolonged-oral-etoposide-as-second-line-therapy-for-platinum-resistant-and/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Peter G. Rose,John A. Blessing,Andrew R. Mayer,H D Homesley |
| Citations | 404 |
| DOI | 10.1200/jco.1998.16.2.405 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W1543697093 |
| PMID | 9469322 |
| Type | article |
| Year | 1998 |

## Paper authors

- [Peter G. Rose](https://scholariq.org/researchers/peter-g-rose/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)

## Paper topics

- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.